1. Home
  2. CVGI vs ADVM Comparison

CVGI vs ADVM Comparison

Compare CVGI & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVGI
  • ADVM
  • Stock Information
  • Founded
  • CVGI 2000
  • ADVM 2006
  • Country
  • CVGI United States
  • ADVM United States
  • Employees
  • CVGI N/A
  • ADVM N/A
  • Industry
  • CVGI Auto Parts:O.E.M.
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CVGI Consumer Discretionary
  • ADVM Health Care
  • Exchange
  • CVGI Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • CVGI 65.1M
  • ADVM 66.3M
  • IPO Year
  • CVGI 2004
  • ADVM 2014
  • Fundamental
  • Price
  • CVGI $1.79
  • ADVM $3.41
  • Analyst Decision
  • CVGI
  • ADVM Strong Buy
  • Analyst Count
  • CVGI 0
  • ADVM 4
  • Target Price
  • CVGI N/A
  • ADVM $19.75
  • AVG Volume (30 Days)
  • CVGI 110.7K
  • ADVM 87.6K
  • Earning Date
  • CVGI 11-03-2025
  • ADVM 11-03-2025
  • Dividend Yield
  • CVGI N/A
  • ADVM N/A
  • EPS Growth
  • CVGI N/A
  • ADVM N/A
  • EPS
  • CVGI N/A
  • ADVM N/A
  • Revenue
  • CVGI $676,815,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • CVGI N/A
  • ADVM $1,836.70
  • Revenue Next Year
  • CVGI $7.19
  • ADVM N/A
  • P/E Ratio
  • CVGI N/A
  • ADVM N/A
  • Revenue Growth
  • CVGI N/A
  • ADVM N/A
  • 52 Week Low
  • CVGI $0.81
  • ADVM $1.78
  • 52 Week High
  • CVGI $3.57
  • ADVM $8.56
  • Technical
  • Relative Strength Index (RSI)
  • CVGI 51.36
  • ADVM 67.68
  • Support Level
  • CVGI $1.63
  • ADVM $2.93
  • Resistance Level
  • CVGI $1.83
  • ADVM $3.25
  • Average True Range (ATR)
  • CVGI 0.10
  • ADVM 0.22
  • MACD
  • CVGI -0.00
  • ADVM 0.05
  • Stochastic Oscillator
  • CVGI 61.54
  • ADVM 84.15

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: